Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06562179 · ClinicalTrials.gov registry record · NA
A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease
A NA study of Hepatopancreaticobiliary and Foregut Operations, sponsored by AdventHealth.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT06562179 is a NA study of Hepatopancreaticobiliary and Foregut Operations that is actively recruiting participants, run by AdventHealth. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06562179, a NA study of Hepatopancreaticobiliary and Foregut Operations, is actively recruiting participants, sponsored by AdventHealth.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect data to evaluate safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in hepatopancreatic biliary (HPB) and Foregut operations. HPB and Foregut operations of this study consist of cholecystectomy, fundoplication, gastrectomy, distal pancreatectomy, pancreaticoduodenectomy, esophagectomy, and hepatectomy.
Conditions Studied
Interventions
- DEVICE da Vinci SP® Single-Port Robotic Surgical System
Study Locations (1)
Florida
- AdventhHealth - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2030-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06562179
The ClinicalTrials.gov registry entry for NCT06562179 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AdventHealth, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hepatopancreaticobiliary and Foregut Operations appearing as the primary indexed condition, and to 1 intervention - of which da Vinci SP® Single-Port Robotic Surgical System is the first listed.
NCT06562179 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06562179 about?
NCT06562179 is a clinical study titled "A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Hepatopancreaticobiliary and Foregut Operations for Benign and Malignant Disease". The purpose of this study is to collect data to evaluate safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in hepatopancreatic biliary (HPB) and Foregut operations. HPB and Foregut operations of this study consist of cholecystectomy, fundoplication, gastrectomy, ...
What is the current status of trial NCT06562179?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2024-05-14. Estimated completion is 2030-06.
What conditions does trial NCT06562179 study?
This clinical trial studies the following conditions: Hepatopancreaticobiliary and Foregut Operations.
What interventions are being tested in trial NCT06562179?
The interventions under investigation include: da Vinci SP® Single-Port Robotic Surgical System (DEVICE).
Who is sponsoring clinical trial NCT06562179?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06562179 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.